{"@context":{"ns0":"http://www.ebi.ac.uk/efo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","obo_purl":"http://purl.obolibrary.org/obo/","metadata_def":"http://data.bioontology.org/metadata/def/","metadata":"http://data.bioontology.org/metadata/"},"@id":"ns0:EFO_0007007","@type":"owl:Class","rdfs:subClassOf":{"@id":"ns0:EFO_0001444"},"rdfs:label":"ticagrelor measurement","obo_purl:IAO_0000115":"Quantification of the amount of ticagrelor in a sample. Ticagrelor is a platelet aggregation inhibitor used for the prevention of thrombotic events in people with acute coronary syndrome or myocardial infarction with ST elevation.","obo_purl:IAO_0000117":"Dani Welter","obo_purl:IAO_0000136":{"@id":"obo_purl:CHEBI_68558"},"ns0:gwas_trait":{"@type":"http://www.w3.org/2001/XMLSchema#boolean","@value":"1"},"metadata:def/prefLabel":"ticagrelor measurement","metadata:def/mappingLoom":"ticagrelormeasurement","metadata:def/mappingSameURI":{"@id":"ns0:EFO_0007007"},"metadata:prefixIRI":"efo:EFO_0007007"}